文献速递慢阻肺

评估COPD患者参与度的工具:晚期生活残疾量表的验证

A Tool to Assess Participation in People With COPD: Validation of the Late Life Disability Instrument.
PubMed 文献 · Chest · 2020-08-31

BACKGROUND: Participation in life roles is a critical patient-centered health outcome associated with morbidity and mortality in older adults, but it is not measured routinely in people with COPD.…

要点

  • LLDI频率和限制域的重测信度均为0.90,测量误差分别为1.74和3.16分。
  • 两域与身体功能、抑郁、生活质量的相关系数在0.38-0.59之间,与焦虑相关性较差。

核心结论

  • LLDI在COPD患者中显示出重测信度、内部一致性以及结构和面部效度,可用于评估该人群的参与度。

主要发现

  • LLDI频率域和限制域的重测信度均为0.90(标准测量误差分别为1.74和3.16分)。
  • 两域与身体功能、抑郁和生活质量的相关系数在0.38-0.59之间。
  • 频率域与焦虑的相关性较差(r=-0.21),限制域为中等(r=-0.45)。
  • 频率域和限制域的Cronbach's α分别为0.69和0.91。

关键数值与推荐

  • 所有医疗专业人员和多数参与者认为LLDI测量参与度(79%)且条目相关(81%)。
  • 两域均无地板或天花板效应。

临床怎么用

  • LLDI可用于评估COPD患者的参与度,辅助识别参与受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Participation in life roles is a critical patient-centered health outcome associated with morbidity and mortality in older adults, but it is not measured routinely in people with COPD. We aimed to validate a participation measure, the Late Life Disability Instrument (LLDI), in people with COPD. RESEARCH QUESTION: To what extent does the LLDI demonstrate test-retest measurement error and reliability, internal consistency, construct and face validity, and floor or ceiling effects when applied to people with COPD? STUDY DESIGN AND METHODS: In this cross-sectional study, LLDI scores were compared with scores on measures of theoretically related constructs and between groups based on symptom severity, prognosis, and frailty. A subsample (n = 36) completed the LLDI a second time over the phone within one week. Participants and health-care professionals were asked about the relevance, comprehensiveness, and comprehensibility of the LLDI. Floor and ceiling effects were explored, and the internal consistency (Cronbach's α) of the LLDI was calculated. RESULTS: Ninety-six older adults with COPD participated. The frequency and limitation domains of the LLDI showed excellent test-retest reliability (two-way random effect intraclass correlation coefficient, 0.90 [standard error of measurement, 1.74 points] and 0.90 [standard error of measurement, 3.16 points], respectively). Both domains showed fair correlations with physical function, depression, and quality of life (r = 0.38-0.59). The relationship with anxiety was poor for the LLDI frequency domain (r = -0.21) and fair for LLDI limitation domain (r = -0.45). Both domains discriminated between people with different symptom severity, prognosis, and frailty (P ≤ .026). Neither domain showed floor or ceiling effects, and Cronbach's α was 0.69 and 0.91 for the LLDI frequency and limitation domains, respectively. All healthcare professionals and most participants agreed that the LLDI measures participation (79%) and that the items were relevant (81%). INTERPRETATION: The LLDI shows test-retest reliability, internal consistency, and construct and face validity in people with COPD. The LLDI can be used to assess participation in this population.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. O'Hoski S, Kuspinar A, Richardson J, et al. A Tool to Assess Participation in People With COPD: Validation of the Late Life Disability Instrument. Chest. 2020. PMID: 32882248. doi:10.1016/j.chest.2020.08.2079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。